PageOverview.com
 

Domains targeting keyword electronic prescribing

Keyword electronic prescribing was used in the provided list of websites.

 
Number of websites/domains displayed: 90
Results found: 141
 

Similar searches:

 

Websites discovered:

Xiidra® (lifitegrast ophthalmic solution) 5% Official ECP Site
http://pageoverview.com/website-report/xiidra-ecp.com
Discover Xiidra® (lifitegrast ophthalmic solution) 5%, indicated to treat both the signs and symptoms of Dry Eye Disease. See Safety and Prescribing Info.
  • Expected expiration: May 13th in 2018
  • Creation date: May 13th in 2016
  • Renew date: April 16th in 2017
Official website | Collagenase SANTYL◊ Ointment
http://pageoverview.com/website-report/santyl.com
Official website for Collagenase SANTYL Ointment. See complete Safety and Prescribing Information on this page.
  • Expected expiration: July 27th in 2019
  • Creation date: July 27th in 1999
  • Renew date: August 2nd in 2017
Levemir® (insulin detemir [rDNA origin] injection) HCP Website
http://pageoverview.com/website-report/levemirpro.com
See information about basal insulin & the long-acting insulin from Levemir®. Read Important Safety & Prescribing Info from the Levemir® HCP Website.
  • Expected expiration: October 28th in 2018
  • Creation date: October 28th in 2010
  • Renew date: November 1st in 2016
  • Google Analytics: 44074826-2
DALVANCE® (dalbavancin) – Official Site
http://pageoverview.com/website-report/dalvance.com
Learn about DALVANCE® and how it can help change the ABSSSI treatment journey. See Full Prescribing & Safety Information.
  • Expected expiration: May 9th in 2019
  • Creation date: May 9th in 2013
  • Renew date: April 8th in 2017
SYMBICORT® (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol For Health Care Professionals
http://pageoverview.com/website-report/symbicorttouchpoints.com
Official HCP site for SYMBICORT, an asthma and COPD treatment, providing information on the inhaler, side effects, dosage and prescribing information.
  • Expected expiration: October 15th in 2017
  • Creation date: October 15th in 2009
  • Renew date: October 11th in 2016
ACC/AHA ASCVD Risk Calculator
http://pageoverview.com/website-report/cvriskcalculator.com
Calculates ASCVD risk for heart disease and stroke using the 2013 ACC/AHA guidelines. Also incorporates JNC-8 blood pressure guidelines and USPSTF aspirin prescribing guidelines.
  • Expected expiration: November 17th in 2017
  • Creation date: November 17th in 2013
  • Renew date: November 18th in 2016
  • Google Analytics: 25772485-3
Interactive Health Partner � Health and Fitness Management
http://pageoverview.com/website-report/interactivehealthpartner.com
The Interactive Health Partner is a comprehensive set of health management tools for prescribing, tracking, and monitoring members' health & fitness activity.
  • Expected expiration: January 4th in 2018
  • Creation date: January 4th in 2007
  • Renew date: March 4th in 2017
Prescribing Services Ltd
http://pageoverview.com/website-report/prescribingservices.org
  • Expected expiration: August 26th in 2018
  • Creation date: August 26th in 2006
  • Renew date: August 26th in 2017
INGREZZA® (valbenazine) for adults with tardive dyskinesia (TD)
http://pageoverview.com/website-report/ingrezza.com
Learn more about INGREZZA—the first FDA-approved treatment for adults with tardive dyskinesia (TD).
  • Expected expiration: December 14th in 2018
  • Creation date: December 14th in 2015
  • Renew date: October 15th in 2017
  • Google Analytics: 76386630-3
Complete Pharmacy Solutions & Best Pharmacy POS System|Myezpharmacy
http://pageoverview.com/website-report/myezpharmacy.org
Myezpharmacy provides complete pharmacy solutions with pharmacy POS system & 24 hour services for healthcare solutions with advanced technology that useful for physicians and pharmacist
  • Expected expiration: December 22nd in 2018
  • Creation date: December 22nd in 2015
  • Renew date: November 28th in 2016
  • Google Analytics: 77199495-1
  • Google Plus Account: +MyEzPharmacy
PrescQIPP
http://pageoverview.com/website-report/prescqipp.info
PrescQIPP - We are an NHS funded not-for-profit organisation that supports quality, optimised prescribing for patients. We produce evidence-based resources and tools for primary care commissioners, and provide a platform to share innovation across the NHS.
  • Expected expiration: June 5th in 2024
  • Creation date: June 5th in 2013
  • Renew date: December 18th in 2017
  • Google Analytics: 3367072-7
Brisdelle® (paroxetine) non-hormonal medication for relief of hot flashes
http://pageoverview.com/website-report/brisdelle.com
Brisdelle® (paroxetine) is a non-hormonal medication indicated for the treatment of hot flashes in menopause. Read the full Prescribing Information, including Boxed WARNING.
  • Expected expiration: April 5th in 2020
  • Creation date: April 5th in 2013
  • Renew date: October 2nd in 2016
  • Google Analytics: 86009080-1
e-Prescribing Software: MDToolbox
http://pageoverview.com/website-report/mdtoolbox.com
MDToolbox e-Prescribing software is designed to easily integrate with EHRs/EMRs/PMs. Add a Surescripts, Meaningful Use and EPCS Certified eRx module into your system with ease.
  • Expected expiration: May 6th in 2019
  • Creation date: May 6th in 2011
  • Renew date: May 7th in 2017
  • Google Analytics: 31829479-1
  • Google Plus Account: +MdtoolboxRx
Patient | PRIALT® (ziconotide) intrathecal infusion
http://pageoverview.com/website-report/prialt.com
Visit the official site for PRIALT. See safety & Prescribing Information, including Warning about possible serious side effects.
  • Expected expiration: February 17th in 2019
  • Creation date: February 17th in 2000
  • Renew date: July 1st in 2017
  • Google Analytics: 6471724-15
Alpha-1 Proteinase Inhibitor | Zemaira
http://pageoverview.com/website-report/zemaira.com
Learn about living with alpha-1 antitrypsin deficiency and Zemaira therapy. See full safety and prescribing information.
  • Expected expiration: October 16th in 2018
  • Creation date: October 16th in 2001
  • Renew date: September 14th in 2016
  • Google Analytics: 418440-13
INVEGA SUSTENNA® (paliperidone palmitate) for HCPs
http://pageoverview.com/website-report/invegasustennahcp.com
Find information for health care professionals about INVEGA® SUSTENNA®. See full safety and Prescribing Information, including boxed WARNING.
  • Expected expiration: July 11th in 2018
  • Creation date: July 11th in 2014
  • Renew date: June 9th in 2017
  • Google Analytics: 70816641-3
Teeth Grinding Bruxism Cure | BruxRelief
http://pageoverview.com/website-report/teethgrindingbruxism.com
Do You Or Anyone You Know Wake Up Each Day With A Sore Jaw? Are You Grinding Away Your Teeth? Is Your Dentist Prescribing Costly Mouth Guards To Protect Your Teeth But You Continue Suffering From The Pain? We've Invented A CURE For Bruxism (Teeth Grinding) Which Affects 1 Out Of 10 Adults. But We Need Your Help To Launch Our Product.
  • Expected expiration: January 31st in 2019
  • Creation date: January 31st in 2017
  • Renew date: February 1st in 2018
  • Google Analytics: 51074959-1
BiDil (isosorbide dinitrate/hydralazine HCl) | Heart Failure Medication
http://pageoverview.com/website-report/bidil.com
BiDil is a prescription medicine used to treat heart failure (HF)… See important safety info & prescribing info.
  • Expected expiration: March 24th in 2019
  • Creation date: March 24th in 2002
  • Renew date: January 23rd in 2017
VELCADE® (bortezomib) Official Website
http://pageoverview.com/website-report/velcade.com
The Official Website for VELCADE® (bortezomib).
  • Expected expiration: March 18th in 2018
  • Creation date: March 18th in 2002
  • Renew date: March 14th in 2017
  • Google Analytics: 7032150-3
EMR, Certified EHR, and Billing Software for Psychologists, Psychiatrists, and Mental Health
http://pageoverview.com/website-report/docutracinc.com
DocuTrac offers easy-to-use software for mental health, behavioral health, and substance abuse agencies including billing, e-prescribing, certified electronic health records, electronic medical records, and more
  • Expected expiration: December 21st in 2018
  • Creation date: December 21st in 2006
  • Renew date: October 26th in 2016
  • Google Analytics: 51903384-1
INGREZZA® (valbenazine) for adults with tardive dyskinesia (TD) | HCP Website
http://pageoverview.com/website-report/ingrezzahcp.com
Get information on INGREZZA safety, dosing, and efficacy to help support your adult patients with TD. See safety and product information.
  • Expected expiration: September 12th in 2019
  • Creation date: September 12th in 2017
  • Renew date: September 12th in 2017
  • Google Analytics: 76386630-4
Duromine 30mg | Approved by TGA. Prescribing information
http://pageoverview.com/website-report/duromine30mg.biz
Credible, relevant, and proven information on Duromine 30mg pills. Guide / Manual for treatment of persons who suffer from overweight & obesity.
  • Expected expiration: February 20th in 2019
  • Creation date: February 21st in 2013
  • Renew date: February 26th in 2018
Moderate to severe plaque psoriasis treatment | TREMFYA™ (guselkumab)
http://pageoverview.com/website-report/tremfya.com
Learn about TREMFYA™ (guselkumab), which is approved for adult patients with moderate to severe plaque psoriasis. See full Prescribing Info & Important Safety Info
  • Expected expiration: February 19th in 2019
  • Creation date: February 19th in 2016
  • Renew date: October 9th in 2017
  • Google Analytics: 70816641-32
Butrans® (buprenorphine) Transdermal System CIII | Official HCP Site
http://pageoverview.com/website-report/butrans.com
Discover Butrans, a Schedule III, extended-release opioid. See Full Prescribing Info, Safety Info & Boxed Warning.
  • Expected expiration: July 10th in 2018
  • Creation date: July 10th in 2003
  • Renew date: June 9th in 2016
Official Site for ADVATE® [Antihemophilic Factor (Recombinant)]
http://pageoverview.com/website-report/advate.com
Learn about ADVATE. Please see the ADVATE Detailed Important Risk Information and full Prescribing Information.
  • Expected expiration: June 3rd in 2024
  • Creation date: June 3rd in 2002
  • Renew date: September 1st in 2016
PARAGARD® (intrauterine copper contraceptive) | Home
http://pageoverview.com/website-report/paragard.com
Learn about PARAGARD—the only hormone-free IUD that’s over 99% effective. It helps prevent pregnancy for up to 10 years, but your HCP can remove it at any time. Please see Important Safety Information and full Prescribing Information on this website.
  • Expected expiration: December 11th in 2017
  • Creation date: December 12th in 1997
  • Renew date: December 6th in 2016
SleepView® Web Portal
http://pageoverview.com/website-report/lucyme.com
Our HIPAA compliant and secure Web Portal offers prescribing physicians online access to patients' sleep test raw data, scoring by registered polysomnographic technologists, and professional interpretation with treatment recommendations by board-certified sleep physicians.
  • Expected expiration: January 21st in 2018
  • Creation date: January 21st in 2009
  • Renew date: January 22nd in 2017
UTIBRON™ NEOHALER® (indacaterol and glycopyrrolate) | Home
http://pageoverview.com/website-report/utibron.com
Learn about UTIBRON™ NEOHALER® (indacaterol/glycopyrrolate), indicated for COPD treatment. See Full Prescribing and Safety Info & BOXED WARNING.
  • Expected expiration: March 17th in 2019
  • Creation date: March 17th in 2015
  • Renew date: March 16th in 2017
Plaque Psoriasis & Psoriatic Arthritis | STELARA® (ustekinumab)
http://pageoverview.com/website-report/stelarainfo.com
Learn about moderate to severe plaque psoriasis & active psoriatic arthritis treatment STELARA®. See Full Prescribing Info & Important Safety Information.
  • Expected expiration: December 4th in 2017
  • Creation date: December 4th in 2008
  • Renew date: May 13th in 2017
  • Google Analytics: 1863405-87
E-Ordering Medical Equipment, Products & Services - Stratice Healthcare
http://pageoverview.com/website-report/edmeplus.net
Electronic ordering, referral and fulfillment of patients' medical equipment, products and care services. Electronic ordering, referral and fulfillment of home and durable medical equipment and supplies. Interoperable, EHR integrated and web-based electronic ordering and prescribing solutions.
  • Expected expiration: July 23rd in 2018
  • Creation date: July 23rd in 2014
  • Renew date: July 24th in 2017
Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma | VALCHLOR (mechlorethamine)
http://pageoverview.com/website-report/valchlor.com
Information for patients about an FDA-approved topical prescription medicine for Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma. Find important safety information medication guide and prescribing information.
  • Expected expiration: October 25th in 2017
  • Creation date: October 25th in 2011
  • Renew date: October 21st in 2016
  • Google Analytics: 55588032-1
Tresiba® Long-Acting Insulin | Tresiba® (insulin degludec injection 100 Units/mL, 200 Units/mL)
http://pageoverview.com/website-report/tresiba.com
Once-daily Tresiba® is a long-acting insulin used to control high blood sugar in adults and children as young as 1 year old with diabetes. Read important safety and prescribing info on this page.
  • Expected expiration: August 27th in 2017
  • Creation date: August 27th in 2010
  • Renew date: September 24th in 2015
Patient Information | ROZEREM (ramelteon)
http://pageoverview.com/website-report/rozerem.com
ROZEREM (ramelteon) is approved for adults having trouble falling asleep from insomnia. Ask your doctor about ROZEREM. See Important Safety Information and Prescribing Information.
  • Expected expiration: February 25th in 2019
  • Creation date: February 25th in 2005
  • Renew date: October 11th in 2017
  • Google Analytics: 5275299-2
TNKase® Acute Myocardial Infarction Treatment
http://pageoverview.com/website-report/tnkase.com
Learn more about single-bolus TNKase® (tenecteplase) acute myocardial infarction treatment and the 5-second TNKase® dosing and administration. Indication For use in mortality reduction associated with acute myocardial infarction (AMI). Treatment should be initiated as soon as possible after the onset of AMI symptoms. Important Safety Information TNKase therapy in patients with acute myocardial infarction is contraindicated in the following certain situations (eg, active internal bleeding, history of cerebrovascular accident, known bleeding diathesis, severe uncontrolled hypertension) because of an increased risk of bleeding [See CONTRAINDICATIONS in full prescribing information]. The most common complication encountered during TNKase therapy is bleeding. Should serious bleeding (not controlled by local pressure) occur, any concomitant heparin or antiplatelet agents should be discontinued immediately. In certain conditions (eg, recent major surgery, cerebrovascular disease, hypertension) the risk of TNKase therapy may be increased and should be weighed against the anticipated benefits. [See WARNINGS in full prescribing information]. Cholesterol embolism has been reported rarely in patients treated with all types of thrombolytic agents; the true incidence is unknown. Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that anti-arrhythmic therapy for bradycardia and/or ventricular irritability be available when TNKase is administered. Please see full Prescribing Information for additional important safety information.
  • Expected expiration: March 13th in 2018
  • Creation date: March 13th in 2000
  • Renew date: October 24th in 2016
VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir, and ritonavir) extended-release tablets
http://pageoverview.com/website-report/viekira.com
Official Site from AbbVie Inc. Please see prescribing information for more about the uses, benefits, and risks of VIEKIRA XR™.
  • Expected expiration: August 20th in 2018
  • Creation date: August 20th in 2013
  • Renew date: July 19th in 2017
Adempas (riociguat) - Official Site
http://pageoverview.com/website-report/adempas-us.com
Adempas (riociguat). Visit Adempas-US.com to see full safety and prescribing information including boxed warning. Learn about Adempas and the Aim Patient Support Program.
  • Expected expiration: March 25th in 2019
  • Creation date: March 25th in 2013
  • Renew date: March 21st in 2017
Janssen CarePath™ Patient Support Program | XARELTO® (rivaroxaban)
http://pageoverview.com/website-report/xareltocarepath.com
Register for the Janssen CarePath Support Program to find valuable cost and savings information. See full Prescribing & Safety Info including Boxed Warnings.
  • Expected expiration: March 17th in 2019
  • Creation date: March 17th in 2011
  • Renew date: March 13th in 2017
  • Google Analytics: 70816641-13
STIVARGA (regorafenib) | Patient Website
http://pageoverview.com/website-report/stivarga-us.com
Learn about STIVARGA (regorafenib). Visit STIVARGA-US.com to see full safety and prescribing information, including boxed warning.
  • Expected expiration: June 6th in 2017
  • Creation date: June 6th in 2012
  • Renew date: June 3rd in 2015
e-Prescribing Integration and Software | DoseSpot
http://pageoverview.com/website-report/dosespot.com
The DoseSpot e-Prescribing platform is your company's prescription to e-Prescribing. Get Surescripts certified as quickly as possible.
  • Expected expiration: September 10th in 2018
  • Creation date: September 10th in 2007
  • Renew date: August 12th in 2015
  • Google Analytics: 46021048-1
Patient Information DEXILANT (dexlansoprazole)
http://pageoverview.com/website-report/dexilant.com
Product information on treatment with DEXILANT (dexlansoprazole) and resources to help you understand and manage your condition. See full safety and prescribing information.
  • Expected expiration: February 10th in 2018
  • Creation date: February 10th in 2010
  • Renew date: November 16th in 2016
  • Google Analytics: 5448303-4
Homepage | SHINGRIX
http://pageoverview.com/website-report/shingrix.com
View the prescribing information for a newly approved vaccine called SHINGRIX and sign up to be the first to get the latest news and information.
  • Expected expiration: February 27th in 2018
  • Creation date: February 27th in 2008
  • Renew date: October 23rd in 2017
Type 2 Diabetes Therapy | Welchol® (colesevelam HCI)
http://pageoverview.com/website-report/welchol.com
Discover Welchol®, which may help patients with type 2 diabetes lower high blood sugar and “bad” cholesterol levels. See Safety & Prescribing Information.
  • Expected expiration: February 2nd in 2018
  • Creation date: February 2nd in 2000
  • Renew date: July 13th in 2012
CINQAIR.com – CINQAIR® (reslizumab) Injection now approved
http://pageoverview.com/website-report/cinqair.com
CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels
  • Expected expiration: November 14th in 2018
  • Creation date: November 14th in 2014
  • Renew date: November 9th in 2017
  • Google Analytics: 75273706-1
eHealthGlobal | Online Pharmacy | Health Care Mobility Solutions - eHealthGlobal
http://pageoverview.com/website-report/ehealthglobal.com
Ehealth Global is cloud based telemedicine software providing e-prescribing, pharmacy software systems, retail pharmacy software, remote medical access, and private virtual clinics.
  • Expected expiration: April 12th in 2018
  • Creation date: April 12th in 2005
  • Renew date: August 12th in 2017
  • Google Analytics: 62630510-5
  • Google Plus Account: +Ehealthglobal
GLP-1 RA Therapy for T2D | Ozempic® (semaglutide) injection 0.5 mg or 1 mg
http://pageoverview.com/website-report/ozempicpro.com
Once weekly Ozempic® for Type 2 diabetes is now available in pharmacies. See Full Prescribing and Safety Information including Boxed Warning.
  • Expected expiration: October 3rd in 2018
  • Creation date: October 3rd in 2016
  • Renew date: September 22nd in 2017
Schizophrenia Medication & Treatment Info | ARISTADA® (aripiprazole lauroxil)
http://pageoverview.com/website-report/aristadahcp.com
Please see Important Safety Information and full Prescribing Information, including Boxed Warning, and Medication Guide.
  • Expected expiration: April 4th in 2020
  • Creation date: April 4th in 2016
  • Renew date: February 3rd in 2017
  • Google Analytics: 66337106-1
ABILIFY® (aripiprazole) | Depression, Bipolar I Disorder, Schizophrenia
http://pageoverview.com/website-report/abilify.com
See Important Safety Info & Prescribing Info, including Boxed WARNING for increased risk of death in some elderly patients & suicidal thoughts or actions.
  • Expected expiration: June 13th in 2018
  • Creation date: June 13th in 2002
  • Renew date: May 27th in 2015
Official Healthcare Professional Site | ORENCIA® (abatacept)
http://pageoverview.com/website-report/orenciahcp.com
Our site offers info for healthcare providers treating patients with moderate to severe rheumatoid arthritis. See Important Safety Info and Prescribing Info.
  • Expected expiration: March 2nd in 2018
  • Creation date: March 2nd in 2015
  • Renew date: February 26th in 2017
Opioid Prescribing Recommendations for Surgery
http://pageoverview.com/website-report/opioidprescribing.info
  • Expected expiration: August 22nd in 2018
  • Creation date: August 22nd in 2017
  • Renew date: October 21st in 2017
  • Google Analytics: 108247433-1
VONVENDI® [von Willebrand factor (Recombinant)] Official Website: For Adults with von Willebrand disease (VWD)
http://pageoverview.com/website-report/vonvendi.com
Learn about VONVENDI for adults with VWD. Please see Detailed Important Risk Information and full Prescribing Information.
  • Expected expiration: February 6th in 2019
  • Creation date: February 6th in 2015
  • Renew date: February 2nd in 2018
INVOKANA® (canagliflozin) Treatment | HCP
http://pageoverview.com/website-report/invokanahcp.com
Learn more about a once-daily treatment option that can help lower blood glucose in adults. See full Prescribing and safety info.
  • Expected expiration: August 14th in 2017
  • Creation date: August 14th in 2012
  • Renew date: May 12th in 2017
  • Google Analytics: 70816641-5
VYXEOS™ (daunorubicin and cytarabine) liposome for injection
http://pageoverview.com/website-report/vyxeos.com
See full Prescribing Information including BOXED Warning. Healthcare professional information about VYXEOS™ (daunorubicin and cytarabine).
  • Expected expiration: August 11th in 2018
  • Creation date: August 11th in 2014
  • Renew date: May 5th in 2017
Electronic Prior Authorization | CenterX | CenterX is a comprehensive e-prescribing network offering electronic prior authorization
http://pageoverview.com/website-report/centerx.com
CenterX is a comprehensive e-prescribing directory service.
  • Expected expiration: November 13th in 2017
  • Creation date: November 13th in 2005
  • Renew date: September 21st in 2016
  • Google Analytics: 33831230-1
  • Google Plus Account: +CenterX1
Synthroid® (levothyroxine sodium tablets, USP) | Official Website
http://pageoverview.com/website-report/synthroid.com
Learn about Synthroid® (levothyroxine sodium tablets, USP) and click for full safety and prescribing information, including important safety information.
  • Expected expiration: December 1st in 2017
  • Creation date: December 2nd in 1996
  • Renew date: February 17th in 2017
Omni Medical Staffing Services – Providing Compassionate MMJ Physicians
http://pageoverview.com/website-report/omnidoctors.com
Compassionate doctors prescribing alternative pain management solutions! - Omni Medical Marijuana Clinic in Metro Detroit, Michigan and Chicago, Illinois
  • Expected expiration: December 14th in 2018
  • Creation date: December 14th in 2016
  • Renew date: December 14th in 2017
  • Google Analytics: 86232423-1
DUPIXENT® (dupilumab) HCP Website
http://pageoverview.com/website-report/dupixenthcp.com
DUPIXENT® is for your adult patients with uncontrolled moderate-to-severe atopic dermatitis. Learn more now. Please see Prescribing Information and Important Safety Information on website.
  • Expected expiration: October 13th in 2018
  • Creation date: October 13th in 2016
  • Renew date: October 13th in 2016
SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII)
http://pageoverview.com/website-report/suboxone.com
SUBOXONE Film along with counseling and psychosocial support may help you—or someone you care about—manage opioid dependence. See full safety and prescribing information.
  • Expected expiration: April 1st in 2018
  • Creation date: April 1st in 1999
  • Renew date: March 28th in 2017
  • Google Analytics: 32458541-1
INVEGA TRINZA® (paliperidone palmitate) | Homepage
http://pageoverview.com/website-report/invegatrinza.com
Learn about INVEGA TRINZA® including condition and treatment information. See full Prescribing and Important Safety Information including Boxed Warning.
  • Expected expiration: October 17th in 2018
  • Creation date: October 17th in 2014
  • Renew date: September 16th in 2017
  • Google Analytics: 614896-47
Fiasp® Fast-Acting Insulin | Fiasp® (insulin aspart injection) 100 U/mL
http://pageoverview.com/website-report/fiasppro.com
Fiasp® is a fast-acting insulin aspart indicated to improve glycemic control in adults with type 1 or type 2 diabetes. Read important safety & prescribing info on this page.
  • Expected expiration: December 20th in 2018
  • Creation date: December 20th in 2016
  • Renew date: December 20th in 2016
  • Google Analytics: 44074826-94
  • AddThis User: ra-57d08e7d95e26a45
Patient Web site for AMRIX® (Cyclobenzaprine Hydrochloride Extended‐Release Capsules)
http://pageoverview.com/website-report/amrix.com
Learn about AMRIX® (Cyclobenzaprine Hydrochloride Extended‐Release Capsules) for the treatment of muscle spasm due to acute, painful musculoskeletal conditions. AMRIX is a prescription medicine used along with rest and physical therapy to help treat muscle spasm due to acute, painful musculoskeletal problems. AMRIX should only be used for up to 2 or 3 weeks. It is not known if AMRIX is effective when used for longer periods. It is not known if AMRIX is safe and effective in children. Do not take AMRIX if you: • are allergic to cyclobenzaprine or any of the components of AMRIX. Talk to your healthcare provider or get medical help right away if you have symptoms of an allergic reaction such as difficulty breathing, hives, swelling of your face or tongue, or itching • are taking certain antidepressants known as monoamine oxidase (MAO) inhibitors, or it has been 14 days or less since you stopped taking a MAO inhibitor. Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure • have had a recent heart attack • have heart rhythm problems (arrhythmias) • have heart failure • have an overactive thyroid (hyperthyroidism). Talk to your healthcare provider before taking this medicine if you have any of the conditions listed above. You should not drink alcohol until you know how AMRIX affects you. Taking AMRIX with alcohol or other medicines that depress your central nervous system can slow your thinking and physical response times. Do not drive, operate machinery, or do other dangerous activities until you know how AMRIX affects you. AMRIX may cause serious side effects that may lead to heart attack or stroke. Call your healthcare provider immediately or go to the nearest hospital emergency room if you have: • irregular or abnormal heartbeats (arrhythmias) • fast heartbeat (tachycardia). Serotonin syndrome is a serious medical condition that may happen when AMRIX is taken with certain other medicines. Call your healthcare provider right away or go to the nearest hospital emergency room if you become severely ill and have some or all of these symptoms: • agitation, hallucinations, coma, or other changes in mental status • coordination problems or muscle twitching (overactive reflexes) • fast heartbeat, high or low blood pressure • sweating or fever • nausea, vomiting, or diarrhea • muscle stiffness or tightness. The most common side effects of AMRIX include dry mouth, dizziness, fatigue, constipation, nausea, upset stomach, and drowsiness. Tell your healthcare provider if you get any side effect that bothers you or that does not go away. These are not all the possible side effects of AMRIX. For more information, talk to your healthcare provider or pharmacist. Please see the Patient Information Leaflet within the accompanying Full Prescribing Information.
  • Expected expiration: November 20th in 2017
  • Creation date: November 20th in 2001
  • Renew date: November 15th in 2016
  • Google Analytics: 38345010-1
EDARBI (azilsartan medoxomil) & EDARBYCLOR (azilsartan medoxomil/chlorthalidone) Tablets
http://pageoverview.com/website-report/edarbi.com
EDARBI & EDARBYCLOR are prescription medicines used to treat high blood pressure (hypertension)… See important safety info & prescribing info, including boxed WARNING.
  • Expected expiration: November 2nd in 2021
  • Creation date: July 28th in 2009
  • Renew date: February 22nd in 2017
EMVERM (mebendazole) | 100-mg Chewable Tablet and Pinworm Treatment
http://pageoverview.com/website-report/emverm.com
EMVERM (mebendazole) 100-mg chewable tablets are a pinworm treatment. Learn more about EMVERM. Only your doctor can determine if EMVERM is right for you.
  • Expected expiration: April 21st in 2018
  • Creation date: April 21st in 2014
  • Renew date: March 17th in 2017
  • Google Analytics: 73325228-3
Factor VIII Therapy for Hemophilia A | AFSTYLA Antihemophilic Factor (Recombinant), Single Chain
http://pageoverview.com/website-report/afstyla.com
Learn about AFSTYLA, a Factor VIII therapy that provides long-lasting bleed protection for people with hemophilia A. Also explore how to get a free 30-day trial.
  • Expected expiration: March 12th in 2019
  • Creation date: March 12th in 2015
  • Renew date: February 9th in 2017
  • Google Analytics: 7437520-74
Iron Deficiency Anemia Treatment | INJECTAFER® HCP
http://pageoverview.com/website-report/injectaferhcp.com
Learn about INJECTAFER® (ferric carboxymaltose injection) for patients with iron deficiency anemia. See Full Prescribing & Safety Info.
  • Expected expiration: May 31st in 2020
  • Creation date: May 31st in 2017
  • Renew date: May 31st in 2017
RightBreathe
http://pageoverview.com/website-report/rightbreathe.com
Inhaler prescribing information
  • Expected expiration: June 14th in 2019
  • Creation date: June 14th in 2016
  • Renew date: September 29th in 2016
  • Google Analytics: 57580228-10
WKO4 | TrainingPeaks
http://pageoverview.com/website-report/wko4.com
Using your athlete’s unique physiology, WKO4 will help you identify individual strengths and weaknesses. You’ll gain faster insights and have confidence in prescribing the most precise training possible.
  • Expected expiration: December 3rd in 2018
  • Creation date: December 3rd in 2012
  • Renew date: December 4th in 2017
  • Google Analytics: 42726244-2
  • Google Plus Account: +trainingpeaks
Treatment with INVOKANA® (canagliflozin)
http://pageoverview.com/website-report/invokana.com
Learn about INVOKANA® (canagliflozin), an SGLT2 inhibitor that helps lower blood sugar in adults. See full prescribing and safety information.
  • Expected expiration: August 15th in 2017
  • Creation date: August 15th in 2012
  • Renew date: August 11th in 2016
  • Google Analytics: 1724827-37
Vraylar® (cariprazine) Bipolar I Disorder & Schizophrenia Treatment
http://pageoverview.com/website-report/vraylar.com
Learn about Vraylar (cariprazine) for acute manic/mixed episodes of Bipolar I disorder & schizophrenia in adults. See risk info, including Boxed Warning & full Prescribing Information.
  • Expected expiration: March 22nd in 2019
  • Creation date: March 22nd in 2011
  • Renew date: March 23rd in 2017
Safe and Effective Opioid Prescribing for Chronic Pain
http://pageoverview.com/website-report/opioidprescribing.com
  • Expected expiration: October 5th in 2017
  • Creation date: October 5th in 2010
  • Renew date: October 6th in 2016
  • Google Analytics: 17849414-1
VALSTAR® (valrubicin) Official Patient Site
http://pageoverview.com/website-report/valstarsolution.com
Learn about VALSTAR® (valrubicin), including safety and side effects, features and risks, and full prescribing information
  • Expected expiration: March 6th in 2019
  • Creation date: March 6th in 2007
  • Renew date: March 2nd in 2018
  • Google Analytics: 43422492-9
KALETRA® (Iopinavir/ritonavir)
http://pageoverview.com/website-report/kaletra.com
Learn about KALETRA® (Iopinavir/ritonavir). Official site from AbbVie Inc. Includes safety and prescribing information.
  • Expected expiration: April 20th in 2018
  • Creation date: April 20th in 2000
  • Renew date: March 19th in 2017
HIV-1 Treatment l Atripla® (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
http://pageoverview.com/website-report/atripla.com
Learn about ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) an HIV-1 treatment. See Safety Info including Boxed WARNING and Full Prescribing Info.
  • Expected expiration: March 29th in 2018
  • Creation date: March 29th in 2005
  • Renew date: March 2nd in 2017
Partial-Onset Seizure & PGTC (Grand Mal) Seizure Treatment | FYCOMPA
http://pageoverview.com/website-report/fycompa.com
Learn more about FYCOMPA, a treatment for partial-onset seizures and PGTC (grand mal) seizures. View Important Safety Information, Boxed Warning and Prescribing Information.
  • Expected expiration: January 31st in 2019
  • Creation date: January 31st in 2011
  • Renew date: November 20th in 2017
Chronic Pain Management | MORPHABOND ER™ (morphine sulfate)
http://pageoverview.com/website-report/morphabondhcp.com
Learn about MORPHABOND ER™ (morphine sulfate), a long-acting opioid indicated for chronic pain. See Full Prescribing & Safety Information, including Boxed Warning.
  • Expected expiration: February 10th in 2020
  • Creation date: February 10th in 2017
  • Renew date: February 10th in 2017
Lifestyle Medicine Global Alliance - Global Vision of True Health Care | A world free of non-communicable disease.
http://pageoverview.com/website-report/lifestylemedicineglobal.org
Creating a New, Global Vision of True Health Care for the 21st Century Medical Professionals Prescribing Lifestyle for Prevention, Treatment and Reversal.
  • Expected expiration: January 25th in 2019
  • Creation date: January 25th in 2016
  • Renew date: December 27th in 2017
  • Google Analytics: 85986528-1
Biosimilar is not the same as REMICADE® (infliximab)
http://pageoverview.com/website-report/finelytuned.com
Learn about staying on REMICADE® (infliximab) if asked to consider a switch to a biosimilar. See full Prescribing & Safety info.
  • Expected expiration: May 10th in 2018
  • Creation date: May 10th in 2002
  • Renew date: March 6th in 2017
DEXILANT (dexlansoprazole) for U.S. Healthcare Professionals
http://pageoverview.com/website-report/dexilanthcp.com
Find DEXILANT (dexlansoprazole) dosing information, clinical data, safety data, and Instant Savings Card information. See Important Safety Information and Prescribing Information.
  • Expected expiration: June 29th in 2018
  • Creation date: June 29th in 2011
  • Renew date: February 22nd in 2017
  • Google Analytics: 29097032-1
REXULTI® (brexpiprazole) | Depression Medication
http://pageoverview.com/website-report/rexulti.com
REXULTI is an add-on treatment for adults with major depressive disorder. See Important Safety Information and Full Prescribing Information, including Boxed WARNING.
  • Expected expiration: October 5th in 2021
  • Creation date: October 5th in 2011
  • Renew date: April 8th in 2016
Ophthalmology EMR Or EHR | Ophthalmic Computer Solution | Retina+ EMR
http://pageoverview.com/website-report/hcit-emr.com
If you are looking for document management software as well as ophthalmology emr or ehr, ambulatory surgery center emr or ehr and e-prescribing, please review our website. If you are also looking for an ophthalmic computer solution as well as retina+ emr, please review our website.
  • Expected expiration: November 26th in 2018
  • Creation date: November 26th in 2003
  • Renew date: November 21st in 2017
  • Google Analytics: 10032509-1
MAVYRET (glecaprevir/pibrentasvir)
http://pageoverview.com/website-report/mavyret.com
Official Site from AbbVie Inc. for patients. View Prescribing Information to learn about the uses, benefits and risks of MAVYRET.
  • Expected expiration: March 7th in 2018
  • Creation date: March 7th in 2017
  • Renew date: July 10th in 2017
ePrescribing Solutions | eazyScripts
http://pageoverview.com/website-report/eazyscripts.com
E-prescribing software doctors actually use.
  • Expected expiration: October 9th in 2022
  • Creation date: October 9th in 2014
  • Renew date: August 10th in 2017
High LDL-C & A1C Therapy | Welchol® (colesevelam HCI)
http://pageoverview.com/website-report/welcholhcp.com
Learn about Welchol® a treatment indicated to treat patients with type 2 diabetes by lowering A1C and LDL-C levels. See Safety & Prescribing Information.
  • Expected expiration: August 12th in 2019
  • Creation date: August 12th in 2010
  • Renew date: July 28th in 2016
NICPLD: Welcome
http://pageoverview.com/website-report/nicpld.org
The Northern Ireland Centre for Pharmacy Learning and Development provides over 1,000 hours of learning opportunity each year to pharmacists, pre-registration trainees and pharmacy technicians.
  • Expected expiration: May 30th in 2018
  • Creation date: May 30th in 2008
  • Renew date: March 21st in 2013
XARELTO® (rivaroxaban) | Prescription Blood Thinner
http://pageoverview.com/website-report/xarelto-us.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
  • Expected expiration: March 16th in 2019
  • Creation date: March 16th in 2009
  • Renew date: March 12th in 2017
  • Google Analytics: 70816641-13
Xealth - A prescription for digital health
http://pageoverview.com/website-report/xealth.io
Xealth is an integrated digital prescribing and analytics platform that enables physicians and care teams to order digital health content, apps, and services as easily as they do medications today.
  • Expected expiration: February 23rd in 2018
  • Creation date: February 23rd in 2016
  • Renew date: June 11th in 2017
  • Google Analytics: 100362062-1
XARELTO® (rivaroxaban) | Prescription Blood Thinner
http://pageoverview.com/website-report/drive4clots.com
Learn about prescription blood thinner XARELTO® including treatment information and cost. See Full Prescribing & Safety Info including Boxed Warnings.
  • Expected expiration: January 15th in 2018
  • Creation date: January 15th in 2015
  • Renew date: December 15th in 2016
  • Google Analytics: 70816641-13
NewCropRx | e-Prescribing | Home
http://pageoverview.com/website-report/newcroprx.com
NewCrop is an industry leading e-prescribing solution that has been deployed in a wide range of EHRs and medical networks since 2003.
  • Expected expiration: November 12th in 2018
  • Creation date: November 12th in 2003
  • Renew date: September 13th in 2015
  • Google Analytics: 72436120-1
Schizophrenia Medication & Treatment Info | ARISTADA® (aripiprazole lauroxil)
http://pageoverview.com/website-report/aristada.com
Please see Important Safety Information and full Prescribing Information, including Boxed Warning, and Medication Guide.
  • Expected expiration: September 18th in 2020
  • Creation date: September 18th in 2012
  • Renew date: July 20th in 2017
  • Google Analytics: 66337106-3
Patient Resources & Information for IMBRUVICA® (ibrutinib)
http://pageoverview.com/website-report/imbruvica.com
Find important information for patients about once-daily IMBRUVICA®. See full prescribing & safety information.
  • Expected expiration: May 11th in 2023
  • Creation date: May 11th in 2013
  • Renew date: April 28th in 2016
  • Google Analytics: 31769815-6
ADCETRIS® (brentuximab vedotin) Patient Website
http://pageoverview.com/website-report/adcetris.com
ADCETRIS® (brentuximab vedotin) injection information for patients. Please see Important Safety and Prescribing Information, including BOXED WARNING.
  • Expected expiration: January 12th in 2021
  • Creation date: January 12th in 2010
  • Renew date: September 20th in 2016
0.1050 // 2024-05-29 19:34:23
All Rights reserved 2018 © PageOverview.com